▶ 調査レポート

世界の線維筋形成異常治療市場予測（～2024年）
• 英文タイトル：Global Fibromuscular Dysplasia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の線維筋形成異常治療市場予測（～2024年） / Global Fibromuscular Dysplasia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR09D3967資料のイメージです。• レポートコード：B-GIR09D3967
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール
• 産業分類：医療・製薬
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Multi User￥772,560 (USD5,220)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートは、線維筋形成異常治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。線維筋形成異常治療の世界市場概観、企業動向、企業別線維筋形成異常治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・線維筋形成異常治療の市場概観
・線維筋形成異常治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・線維筋形成異常治療の企業別販売動向、市場シェア、市場集中度、競争動向
・線維筋形成異常治療の世界市場規模
・線維筋形成異常治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・線維筋形成異常治療のアメリカ市場規模推移
・線維筋形成異常治療のカナダ市場規模推移
・線維筋形成異常治療のメキシコ市場規模推移
・線維筋形成異常治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・線維筋形成異常治療のドイツ市場規模推移
・線維筋形成異常治療のイギリス市場規模推移
・線維筋形成異常治療のロシア市場規模推移
・線維筋形成異常治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・線維筋形成異常治療の日本市場規模推移
・線維筋形成異常治療の中国市場規模推移
・線維筋形成異常治療の韓国市場規模推移
・線維筋形成異常治療のインド市場規模推移
・線維筋形成異常治療の東南アジア市場規模推移
・線維筋形成異常治療の南米市場分析（ブラジル、アルゼンチン等）
・線維筋形成異常治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・線維筋形成異常治療の種類別分析/販売量、売上、市場シェア（手術療法、薬物療法）
・線維筋形成異常治療の用途別分析/市場規模（病院、診療所、その他）
・線維筋形成異常治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・線維筋形成異常治療の販売チャネル・代理店・貿易業者・ディーラー分析

Fibromuscular dysplasia (FMD) is a disease that causes abnormal cell development in the artery wall, which results in narrowing, i.e., stenosis, and enlargement, i.e., aneurysm of the medium-sized arteries in the body.

Scope of the Report:
The global Fibromuscular Dysplasia Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Fibromuscular Dysplasia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Fibromuscular Dysplasia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Fibromuscular Dysplasia Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
Bayer
Merck
Novartis
Bristol-Myers Squibb
AstraZeneca
Allergan
Medtronic
BD
Smith & Nephew
Stryker
B. Braun Melsungen
Johnson & Johnson
Hill-Rom
Alkermes Pharma Ireland
Dainippon Sumitomo Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Surgery Therapy
Medication

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Fibromuscular Dysplasia Treatment Market Overview
1.1 Product Overview and Scope of Fibromuscular Dysplasia Treatment
1.2 Classification of Fibromuscular Dysplasia Treatment by Types
1.2.1 Global Fibromuscular Dysplasia Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Fibromuscular Dysplasia Treatment Revenue Market Share by Types in 2018
1.2.3 Surgery Therapy
1.2.4 Medication
1.3 Global Fibromuscular Dysplasia Treatment Market by Application
1.3.1 Global Fibromuscular Dysplasia Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Fibromuscular Dysplasia Treatment Market by Regions
1.4.1 Global Fibromuscular Dysplasia Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Fibromuscular Dysplasia Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Fibromuscular Dysplasia Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Fibromuscular Dysplasia Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Fibromuscular Dysplasia Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Fibromuscular Dysplasia Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Fibromuscular Dysplasia Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Fibromuscular Dysplasia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Fibromuscular Dysplasia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Fibromuscular Dysplasia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Fibromuscular Dysplasia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Fibromuscular Dysplasia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Fibromuscular Dysplasia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 Fibromuscular Dysplasia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Allergan
2.8.1 Business Overview
2.8.2 Fibromuscular Dysplasia Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Allergan Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Medtronic
2.9.1 Business Overview
2.9.2 Fibromuscular Dysplasia Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Medtronic Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 BD
2.10.1 Business Overview
2.10.2 Fibromuscular Dysplasia Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BD Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Smith & Nephew
2.11.1 Business Overview
2.11.2 Fibromuscular Dysplasia Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Smith & Nephew Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Stryker
2.12.1 Business Overview
2.12.2 Fibromuscular Dysplasia Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Stryker Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 B. Braun Melsungen
2.13.1 Business Overview
2.13.2 Fibromuscular Dysplasia Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 B. Braun Melsungen Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Fibromuscular Dysplasia Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 Hill-Rom
2.15.1 Business Overview
2.15.2 Fibromuscular Dysplasia Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hill-Rom Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.16 Alkermes Pharma Ireland
2.16.1 Business Overview
2.16.2 Fibromuscular Dysplasia Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Alkermes Pharma Ireland Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.17 Dainippon Sumitomo Pharma
2.17.1 Business Overview
2.17.2 Fibromuscular Dysplasia Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Dainippon Sumitomo Pharma Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Fibromuscular Dysplasia Treatment Market Competition, by Players
3.1 Global Fibromuscular Dysplasia Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Fibromuscular Dysplasia Treatment Players Market Share
3.2.2 Top 10 Fibromuscular Dysplasia Treatment Players Market Share
3.3 Market Competition Trend
4 Global Fibromuscular Dysplasia Treatment Market Size by Regions
4.1 Global Fibromuscular Dysplasia Treatment Revenue and Market Share by Regions
4.2 North America Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
5 North America Fibromuscular Dysplasia Treatment Revenue by Countries
5.1 North America Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
5.2 USA Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
6 Europe Fibromuscular Dysplasia Treatment Revenue by Countries
6.1 Europe Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
6.2 Germany Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
6.4 France Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Fibromuscular Dysplasia Treatment Revenue by Countries
7.1 Asia-Pacific Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
7.2 China Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
7.5 India Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
8 South America Fibromuscular Dysplasia Treatment Revenue by Countries
8.1 South America Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
8.2 Brazil Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Fibromuscular Dysplasia Treatment by Countries
9.1 Middle East and Africa Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
10 Global Fibromuscular Dysplasia Treatment Market Segment by Type
10.1 Global Fibromuscular Dysplasia Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Fibromuscular Dysplasia Treatment Market Forecast by Type (2019-2024)
10.3 Surgery Therapy Revenue Growth Rate (2014-2024)
10.4 Medication Revenue Growth Rate (2014-2024)
11 Global Fibromuscular Dysplasia Treatment Market Segment by Application
11.1 Global Fibromuscular Dysplasia Treatment Revenue Market Share by Application (2014-2019)
11.2 Fibromuscular Dysplasia Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2024)
12.1 Global Fibromuscular Dysplasia Treatment Market Size Forecast (2019-2024)
12.2 Global Fibromuscular Dysplasia Treatment Market Forecast by Regions (2019-2024)
12.3 North America Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
12.6 South America Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Fibromuscular Dysplasia Treatment Picture
Table Product Specifications of Fibromuscular Dysplasia Treatment
Table Global Fibromuscular Dysplasia Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Fibromuscular Dysplasia Treatment Revenue Market Share by Types in 2018
Figure Surgery Therapy Picture
Figure Medication Picture
Table Global Fibromuscular Dysplasia Treatment Revenue (Million USD) by Application (2014-2024)
Figure Fibromuscular Dysplasia Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Fibromuscular Dysplasia Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Fibromuscular Dysplasia Treatment Type and Applications
Table Pfizer Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Fibromuscular Dysplasia Treatment Type and Applications
Table Sanofi Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Fibromuscular Dysplasia Treatment Type and Applications
Table Bayer Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Fibromuscular Dysplasia Treatment Type and Applications
Table Merck Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Fibromuscular Dysplasia Treatment Type and Applications
Table Novartis Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Fibromuscular Dysplasia Treatment Type and Applications
Table Bristol-Myers Squibb Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Fibromuscular Dysplasia Treatment Type and Applications
Table AstraZeneca Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Fibromuscular Dysplasia Treatment Type and Applications
Table Allergan Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Fibromuscular Dysplasia Treatment Type and Applications
Table Medtronic Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Fibromuscular Dysplasia Treatment Type and Applications
Table BD Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Smith & Nephew Basic Information, Manufacturing Base and Competitors
Table Smith & Nephew Fibromuscular Dysplasia Treatment Type and Applications
Table Smith & Nephew Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Stryker Basic Information, Manufacturing Base and Competitors
Table Stryker Fibromuscular Dysplasia Treatment Type and Applications
Table Stryker Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen Fibromuscular Dysplasia Treatment Type and Applications
Table B. Braun Melsungen Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Fibromuscular Dysplasia Treatment Type and Applications
Table Johnson & Johnson Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hill-Rom Basic Information, Manufacturing Base and Competitors
Table Hill-Rom Fibromuscular Dysplasia Treatment Type and Applications
Table Hill-Rom Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Alkermes Pharma Ireland Basic Information, Manufacturing Base and Competitors
Table Alkermes Pharma Ireland Fibromuscular Dysplasia Treatment Type and Applications
Table Alkermes Pharma Ireland Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dainippon Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table Dainippon Sumitomo Pharma Fibromuscular Dysplasia Treatment Type and Applications
Table Dainippon Sumitomo Pharma Fibromuscular Dysplasia Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Fibromuscular Dysplasia Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue Share by Players (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Players in 2017
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Fibromuscular Dysplasia Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Fibromuscular Dysplasia Treatment Revenue Market Share in 2018
Figure Global Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Market Share by Regions in 2018
Figure North America Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure South America Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table North America Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
Table North America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries in 2018
Figure USA Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table Europe Fibromuscular Dysplasia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Fibromuscular Dysplasia Treatment Revenue Market Share by Countries in 2018
Figure Germany Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure UK Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure France Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Fibromuscular Dysplasia Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Fibromuscular Dysplasia Treatment Revenue Market Share by Countries in 2018
Figure China Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure India Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table South America Fibromuscular Dysplasia Treatment Revenue by Countries (2014-2019)
Table South America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Fibromuscular Dysplasia Treatment Revenue Market Share by Countries in 2018
Figure Brazil Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Fibromuscular Dysplasia Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Fibromuscular Dysplasia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Fibromuscular Dysplasia Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Fibromuscular Dysplasia Treatment Revenue and Growth Rate (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue Share by Type (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Type (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Type in 2019
Table Global Fibromuscular Dysplasia Treatment Revenue Forecast by Type (2019-2024)
Figure Global Fibromuscular Dysplasia Treatment Market Share Forecast by Type (2019-2024)
Figure Global Surgery Therapy Revenue Growth Rate (2014-2019)
Figure Global Medication Revenue Growth Rate (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue by Application (2014-2019)
Table Global Fibromuscular Dysplasia Treatment Revenue Share by Application (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Application (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue Share by Application in 2019
Table Global Fibromuscular Dysplasia Treatment Revenue Forecast by Application (2019-2024)
Figure Global Fibromuscular Dysplasia Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Fibromuscular Dysplasia Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Fibromuscular Dysplasia Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Fibromuscular Dysplasia Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
Figure Europe Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
Figure South America Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Fibromuscular Dysplasia Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 気管支肺異形成症市場：世界及び中国市場分析・予測（～2024年）
    Bronchopulmonary Dysplasia Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT1088 2019年10月1日 138Pages
    「気管支肺異形成症市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における気管支肺異形成症市場について調査・分析したレポートで、気管支肺異形成症の世界市場動向、市場規模、主要企業情報などが含まれています。気管支肺異形成症のタイプ別には、界面活性剤補充療法、酸素療法、支持療法、その他...
  • 世界の腱炎治療市場予測（～2024年）
    Global Tendinitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4320 2019年9月18日 124Pages
    本調査レポートは、腱炎治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腱炎治療の世界市場概観、企業動向、企業別腱炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米...
  • 世界の髄膜炎菌感染症治療市場予測（～2024年）
    Global Meningococcal Infections Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4126 2019年9月18日 101Pages
    本調査レポートは、髄膜炎菌感染症治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、グルココルチコイド、プロテインC濃縮物等、用途別セグメントは、病院、診療所、その他等に区分しました。髄膜炎菌感染症治療の世界市場概観、企業動向、企業別髄膜炎菌感染症治療シェア、市場規模推移、市場規...
  • 世界のアナフィラキシー治療市場予測（～2024年）
    Global Anaphylaxis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3773 2019年9月18日 116Pages
    本調査レポートは、アナフィラキシー治療の世界市場について調べ、まとめました。種類別セグメントは、経口、非経口、その他等、用途別セグメントは、食物アレルギー、花粉アレルギー、ホコリダニアレルギー、その他等に区分しました。アナフィラキシー治療の世界市場概観、企業動向、企業別アナフィラキシー治療シェア、市...
  • 世界の咽頭後膿瘍治療市場予測（～2024年）
    Global Retropharyngeal Abscess Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4264 2019年9月18日 124Pages
    本調査レポートは、咽頭後膿瘍治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、鎮痛剤、外科ドレナージ、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。咽頭後膿瘍治療の世界市場概観、企業動向、企業別咽頭後膿瘍治療シェア、市場規模推移、市場規模予測（2019年-...
  • 世界の子宮肉腫治療市場予測（～2024年）
    Global Uterine Sarcoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4349 2019年9月18日 122Pages
    本調査レポートは、子宮肉腫治療の世界市場について調べ、まとめました。種類別セグメントは、手術、放射線療法、ホルモン療法等、用途別セグメントは、病院、診療所、その他等に区分しました。子宮肉腫治療の世界市場概観、企業動向、企業別子宮肉腫治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主...
  • 世界のレフサム病治療市場予測（～2024年）
    Global Refsum Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4255 2019年9月18日 119Pages
    本調査レポートは、レフサム病治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。レフサム病治療の世界市場概観、企業動向、企業別レフサム病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域...
  • 世界の百日咳治療市場予測（～2024年）
    Global Pertussis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4194 2019年9月18日 121Pages
    本調査レポートは、百日咳治療の世界市場について調べ、まとめました。種類別セグメントは、アジスロマイシン、クラリスロマイシン、エリスロマイシン、その他等、用途別セグメントは、子供、大人等に区分しました。百日咳治療の世界市場概観、企業動向、企業別百日咳治療シェア、市場規模推移、市場規模予測（2019年-...
  • 世界の緑内障治療市場予測（～2024年）
    Global Glaucoma Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3994 2019年9月18日 118Pages
    本調査レポートは、緑内障治療の世界市場について調べ、まとめました。種類別セグメントは、プロスタグランジンアナログ（PGA）、ベータブロッカー、アルファアゴニスト等、用途別セグメントは、クリニック、薬局、その他等に区分しました。緑内障治療の世界市場概観、企業動向、企業別緑内障治療シェア、市場規模推移、...
  • 世界のダンピング症候群治療市場予測（～2024年）
    Global Dumping Syndrome Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3928 2019年9月18日 124Pages
    本調査レポートは、ダンピング症候群治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法等、用途別セグメントは、病院、診療所、その他等に区分しました。ダンピング症候群治療の世界市場概観、企業動向、企業別ダンピング症候群治療シェア、市場規模推移、市場規模予測（2019年-20...
  • 気管支肺異形成症市場：世界及び中国市場分析・予測（～2024年）気管支肺異形成症市場：世界及び中国市場分析・予測（～2024年） Bronchopulmonary Dysplasia Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bronchopulmonary Dysplasia industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bronchopulmonary…
  • 世界の腱炎治療市場予測（～2024年）世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
  • 世界のレフサム病治療市場予測（～2024年）世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…
  • 世界の無眼球症および小眼球症治療市場予測（～2024年）世界の無眼球症および小眼球症治療市場予測（～2024年） Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in which one or both eyes are abnormally small, while anophthalmia is the absence of one or both eye…
  • 世界のダンピング症候群治療市場予測（～2024年）世界のダンピング症候群治療市場予測（～2024年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…